The human papillomavirus (HPV) life cycle is tightly linked to differentiation of the infected epithelium. This means that viral proteins must exert control over epithelial gene expression in order to optimize viral production. The HPV E2 protein controls replication, transcription and viral genome partitioning during the viral infectious life cycle. It consists of a nucleic acid-binding domain and a protein-protein interaction domain separated by a flexible serine and arginine-rich hinge region. Over the last few years, mounting evidence has uncovered an important new role for E2 in viral and cellular RNA processing. This Gem discusses the role of E2 in controlling the epithelial cellular environment and how E2 might act to coordinate late events in the viral replication cycle.
The human papillomavirus life cycle
Human papillomaviruses (HPV) are small (~8.0 kbp) circular double stranded DNA viruses that infect epithelial cells (keratinocytes) (1). There are over 200 HPV genotypes. For the most part, HPVs of the α-genotype group infect mucosal epithelia while the β-genotypes predominantly infect cutaneous epithelia (2) . Most HPV infections are asymptomatic or they manifest as benign lesions or warts. They are usually transient and are eventually cleared by the immune system (3) . Despite this, HPVs cause a high burden of clinically significant disease worldwide because the anogenital mucosal-infective "high risk" group of HPVs (HR-) HPVs can cause persistent infection that leads to epithelial dysplasia, and neoplasia. HR-HPVs are commonly associated with cervical cancer and tumors of other anogenital sites (2) .
Per annum, worldwide, there are around 500,000 new cases of cervical disease and around 270,000 women die from cervical cancer. The two most prevalent HR-HPVs are HPV16 and 18 that are targeted by the current HPV vaccines (4) . Over the last few decades, epidemic HR-HPV infection, especially in men, has been associated with a significant increase in oropharyngeal cancers (5) . Certain cutaneous HPVs can also cause tumours (squamous cell carcinomas) in immunocompromised or immunosuppressed individuals (6) . Thus the causative association of HPV infection with a number of significant cancers indicates that increased understanding of the viral life cycle is essential.
The HPV life cycle is intimately linked to epithelial differentiation ( Figure 1A ) (2) . HPV normally infects dividing cells at the base of the epithelium (basal layer) but completes its life cycle by amplifying progeny DNA genomes in the mid epithelial layers (spinous layer) and carrying out viral encapsidation in the uppermost epithelial layer (granular layer) ( Figure 1A ). Viral production is achieved through a highly orchestrated and complex viral gene expression program ( Figure 1A ) (2) . Mature virions are released upon shedding and disintegration of dead superficial epithelial cells into the environment. As a necessity, HPV infection alters the normal differentiation pattern of the epithelium and controls cellular gene expression to support viral replication (2) . In short, differentiating cells in the mid-epithelial layers are induced into cell division and epithelial differentiation is somewhat delayed.
RNA processing
Cellular and viral gene expression is controlled at both the transcriptional and posttranscriptional levels. Post-transcriptional events include RNA processing (the expression of mature messenger RNA (mRNA) from the primary transcript (premRNA), by capping, polyadenylation, and splicing), mRNA export from the nucleus to the cytoplasm, mRNA stability, and mRNA translation on the ribosomes. Tight control of all of these events is essential to ensure the appropriate profile of protein production in the cell. Splicing is the process by which non-coding introns are removed from pre-mRNAs and exons are spliced together to form a protein-coding mRNA. However, premRNAs transcribed from multi-exon/intron genes can undergo a process termed alternative splicing (7) . Alternative splicing is a regulated process in which a primary transcript can be spliced in more than one pattern (exon removal or retention) to generate multiple, distinct "splice isoform" mRNAs. For example, the average human gene can give rise to eight different mRNA isoforms each encoding a different protein isoform, meaning that alternative splicing is a key player in determining the final cellular protein profile. Alternative splicing is crucial for the life cycle of some viruses such as HIV which expresses over forty different alternatively spliced mRNAs (8) .
Splicing is controlled by specific cellular activators (serine-arginine-rich splicing factors (SRSFs)) and repressors (heterogeneous nuclear ribonucleoproteins (hnRNPs)) (9) . There are nine classical SRSFs (SRSF1-9) (10) that consist of at least one RNA recognition motif (RRM) that binds the pre-mRNA and one serinearginine-rich domain that interacts with partner proteins such as other splicing factors (11) .
The serine-arginine domain can undergo cycles of phosphorylation/dephosporylation to control splicing, protein-protein interactions and subcellular location (11) . The relative levels of SRSF proteins are pivotal in maintaining the correct balance of cellular mRNA isoforms in normal cells while overexpression of some SRSF proteins has been shown to lead to cancer progression (12) .
Splicing occurs co-transcriptionally, linked through the carboxy-terminal domain of RNA polymerase II, which acts as a landing pad to recruit mRNA processing factors (13) . Moreover, SRSFs have been shown to regulate elongation of transcription by RNA polymerase II (13) . Apart from regulating transcription and splicing, SRSFs have multiple other roles in the cell, including regulating polyadenylation, nuclear export, mRNA stability, translation, genome stability maintenance, nucleolar stress, cell cycle progression, control of apoptosis, and protein sumoylation (12) . This means that SRSFs can coordinately control transcription and splicing in the nucleus while also providing a link to other post-transcriptional processes and the cellular environment.
HPV E2
E2 plays a crucial role in the HPV life cycle (14) . It possesses a DNA-binding domain and a transactivation domain that are linked by a serine-arginine-rich hinge region ( Figure 1B ) (15) . E2 is normally found as a homodimer that binds cognate sequences (E2-binding sites (E2BSs)) in the viral long control region (LCR) ( Figure 1C ), which contains the viral early promoter, origin of replication, enhancer and upstream, the late 3' UTR and polyadenylation sites (not shown in Figure 1C ). For the mucosalinfective HPVs, two E2BSs are proximal to the viral early promoter, the third is located at the origin of DNA replication, and the fourth is located in the enhancer region ( Figure 1C ) (14) . E2 has been shown to be capable of either activating or repressing transcription in different experimental systems. However, the evidence points to a repressive function of E2 in controlling the viral early promoter (14) . On the other hand, the most important role of E2 may be as an auxiliary replication factor. At the origin of DNA replication, E2 interacts with and loads the HPV E1
replication helicase, which in turn recruits the cellular DNA replication machinery (14) . E2 also has an important role in partitioning viral episomal genomes during division of infected cells by interacting with chromatin adapter proteins that tether them to host mitotic chromosomes (14) .
E2 as a serine-arginine-rich splicing factor (SRSF)
It addition to its DNA-related roles, there is evidence that E2 can bind RNA and has properties and functions similar to those of SRSF splicing regulators. Like the serinearginine domain in which phosphorylation controls the function of SRSF proteins, the long hinge region (130-209 amino acids) of some β-type E2 proteins is rich in serine and arginine residues and can be phosphorylated (16, 17) . Like all SR proteins, E2 is normally located in the nucleus (18) and, at least for HPV1 and HPV5, can be found in nuclear speckles (16, 19) , the storage sites of splicing factors in the nucleus. HR-HPV E2 proteins can also shuttle between the nucleus and the cytoplasm (20) . An early report indicated that the β-genotype HPV5 E2, which carries a long hinge region, could regulate both transcription and splicing of reporter pre-mRNAs (19) .
However, a later study could not verify this finding and instead found that the α-genotype HPV16 E2, which possesses a much shorter hinge region (14) , could inhibit splicing in vitro (21) . Although E2 does not possess an RNA recognition motif required by the SRSFs for RNA binding (11) , one study showed HPV16 E2 could bind RNA directly via its carboxy-terminal domain in a UV crosslinking assay (21).
However, improved approaches such as cross-linking immunoprecipitation (CLIP) in vivo are required before E2 can be considered a true RNA-binding protein.
The cellular interactomes of E2 proteins from a range of different HPV genotypes have been dissected by two studies.
Although not yet critically evaluated in most cases, as expected, many E2-interacting proteins are transcription or replication or chromatin remodelling factors or histone modifying enzymes (22, 23) . E2 also interacts with proteins involved in apoptosis regulation, cell cycle, keratinocyte migration and differentiation, and intracellular transport. Although the majority of E2
interactors are involved in processes related to transcription, replication, or chromatin remodelling, the next most frequently identified set of proteins are involved in RNA processing. These proteins included components of the basic splicing machinery such as SMN, SF1, and U170K (Table 1 ). In addition, serine-arginine protein kinases (SRPKs), which control SRSFs through phosphorylation (24), were also detected (22, 23, 25) . Of particular note, E2 from most of the genotypes tested interacted with the splicing activators SRSF1, 2, and 7 and 10 (Tra2β) (22, 23) . The involvement of E2 in post-transcriptional as well as transcriptional processes is perhaps unsurprising, given the close association between transcription and RNA processing. These studies suggest that E2 may integrate viral transcription and RNA processing, leading to efficient production of processed viral mRNAs. Although further work is required to support this hypothesis, it is clear that E2 has properties suggestive of a role in controlling pre-mRNA splicing by recruiting cellular splicing factors.
E2 as a regulator of SRSFs
In normal keratinocytes, E2 is detected at highest levels in the mid to upper epithelial layers ( Figure 1A ) (26) where viral vegetative replication takes place. Interestingly, expression of the late mRNAs that encode the viral capsid proteins also begins in these layers ( Figure 1A ) (27, 28) . In vivo, SRSF expression is highest in uninfected, undifferentiated basal epithelial cells. However, SRSF levels are high in infected cells in differentiated HPV-infected keratinocytes ( Figure 1A ), (29, 30) . Specifically, HPV16
and HPV31 E2 can transcriptionally up-regulate expression of at least SRSFs 1, 2 and 3 ( Figure 1D ) (31) . This exciting finding implies that, because the relative levels of SRSFs in a cell determine alternative splicing outcomes and thus the overall has a pivotal role to play in controlling cellular and viral splicing, and may regulate splicing by stimulating SRSF expression, acting as an SRSF to regulating splicing directly, or modulating SRSF activity through direct binding.
E2 controls late events in viral replication
Apart from E1, there is evidence that E2 can bind other viral proteins such as E4 (33) trans-activation function showed no effect on viral replication but a reduction of 80% in viral late mRNA expression (38) . Recently, we extended this observation to show that in keratinocytes maintaining E2:I73L mutant genomes there was a 75% decrease in capsid protein production compared with wild-type HPV31 genomes (31) . SRSF1, 2, and 3 levels in the E2:I73L genome-containing cells were all significantly reduced, in agreement with wild-type E2 trans-activation of the promoters of the genes encoding these proteins ( Figure 1D ). In order to discover which SRSF protein was responsible for controlling capsid protein expression, 
